Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
C OM PR E H E NS I V E Radiation Technology Accelerated Partial Breast Irradiation (APBI), a type of brachytherapy, is localized treatment that delivers a highly effective dose of radiation to a specific part of the breast where the tumor was removed. APBI involves the insertion of a catheter to kill any cancer cells that may remain after lumpectomy surgery. This procedure requires close collaboration between the surgeon who removes the breast tumor, and the radiation oncologist who treats the tumor area after surgery. Accelerated partial breast irradiation is performed approximately one to four weeks after a lumpectomy. The device which delivers the radiation remains in place for the duration of the treatment. The procedure is given twice a day over a period of five to seven days. This treatment time is much shorter than external beam radiation which involves five treatments a week for three and a half to seven weeks. Comprehensive Cancer Centers of Nevada (CCCN) is accredited by the American College of Radiology, having earned the accreditation for five consecutive three year terms. Working in tandem with our advanced treatment planning systems, the purpose of radiation therapy is to eradicate cancerous cells and to prevent them from growing or dividing, while minimizing adverse effects on nearby healthy organs and tissues. At CCCN, we offer the most precise radiation applications and state-of-the-art equipment available, including: • • • • • • • • • Three-dimensional Conformal Radiation Therapy Intensity Modulated Radiation Therapy Image-Guided Radiation Therapy Volumetric Modulated Arc Therapy CyberKnife® Radiosurgery Stereotactic Radiosurgery High Dose Rate Brachytherapy, Prostate Seed Brachytherapy Accelerated Partial Breast Irradiation Clinical Research CyberKnife® Radiosurgery is exclusive to CCCN and is the most powerful advancement in cancer treatment ever available in Southern Nevada. Operated by CCCN’s own specially trained radiation oncologists, CyberKnife can target and eradicate tumors anywhere on the body with incredible precision. CyberKnife is utilized to treat brain tumors, head and neck tumors, lung tumors, liver lesions, prostate cancer, spine tumors, previously irradiated tumors and many other hard-to-reach tumor sites. CyberKnife delivers a much higher dose of radiation in as many as one to five treatments. In order to spare surrounding healthy tissue from exposure, CyberKnife relies on precision and accuracy. CyberKnife can be used as an alternative to invasive surgery or weeks of external beam radiotherapy treatments or can be highly useful as an adjunctive therapy in combination with conventional radiation therapy or chemotherapy to maximize treatment efficacy. High Dose Rate Brachytherapy (HDR) uses a radioactive source that is placed inside the tumor site to be treated. Then, a high dose of radiation is given to a limited area, sparing the surrounding normal tissue. HDR brachytherapy lasts only a few minutes in the outpatient setting and causes little discomfort, fewer complications, and a quicker recovery time. Intensity Modulated Radiation Therapy (IMRT) uses threedimensional imaging to deliver very precise radiation doses to the tumor while sparing the normal organs. In some tumor types such as prostate cancer, this technology can deliver higher doses of radiation therapy while reducing the amount of radiation exposure to surrounding healthy tissue. Image-Guided Radiotherapy (IGRT) uses ultrasound, a CT scan, or X-rays to capture images of the treatment area before delivering radiation, and is often used to treat cancers in organs that move, such as the prostate or lung. The use of the highly precise IGRT treatments result in the surrounding healthy tissue receiving less radiation exposure while also reducing radiotherapy side effects. Stereotactic Radiosurgery (SRS) is ideal for treating brain tumors and lesions that cannot be treated by traditional surgical methods. SRS uses a computerguided radiation therapy system to aim highly-focused beams of radiation directly into brain tumors and other brain abnormalities; the vital areas of the brain are spared from the high doses of radiation, thus decreasing the risk of side effects. The procedure is typically performed in a one-day session on an outpatient basis under local anesthesia. Patients usually return home shortly after the procedure. Volumetric Modulated Arc Therapy (VMAT) uses IMRT and IGRT to deliver high precision radiation treatments, and can complete treatments in 30 to 90 seconds. Groundbreaking Clinical Research at CCCN, where the practice conducts more than 170 Phase I, Phase II and Phase III clinical trials each year. As a result of its active research program, the practice was one of two sites in the United States that were instrumental in a new groundbreaking radio-immunotherapy drug that obtained approval from the Food and Drug Administration. The drug is called Xofigo (zhō-fi-go) and its active ingredient Radium 223 dichloride, is a form of ‘liquid radiation’ that fights prostate cancer that spreads to the bones. It specifically targets prostate cancer cells that spread to the bone, and leaves unaffected normal tissues untouched. The latter feature is a breakthrough in modern medicine since prostate cancer metastasizes to the bones of many prostate cancer patients. The therapy is administered intravenously and has multiple advantages including less pain and fewer side effects. CCCN also offers other radio-immunotherapies such as Zevalin therapy and Quadramet therapy. The practice is a leader in conducting clinical research to offer patients treatment options other than the typical standard of care. Radiation Oncology Treatment Centers N 1 5 N. Hualapai Way 3 2 = Hospital 1 2 4 3 4 5 NORTHWEST SOUTHWEST CENTRAL VALLEY HENDERSON SUMMERLIN 7445 Peak Drive Las Vegas, NV 89128 Tel: 702.952.2140 Fax: 702.952.2148 9280 W. Sunset Road Suite 100 Las Vegas, NV 89148 Tel: 702.952.1251 Fax: 702.952.1241 3730 S. Eastern Avenue Las Vegas, NV 89169 Tel: 702.952.3400 Fax: 702.952.3713 10001 S. Eastern Avenue Suite 108 Henderson, NV 89052 Tel: 702.952.3444 Fax: 702.952.3485 655 N. Town Center Drive Las Vegas, NV 89144 Tel: 702.233.2200 Fax: 702.233.2210 Andrew M. Cohen, MD Michael T. Sinopoli, MD Raul T. Meoz, MD, FACR Michael J. Anderson, MD Farzaneh Farzin, MD cccnevada.com • 702.952.3350 Michael J. Anderson, MD Matthew Schwartz, MD Dan L. Curtis, MD Raul T. Meoz, MD, FACR Michael T. Sinopoli, MD